» Articles » PMID: 28424515

Structure and Allosteric Inhibition of Excitatory Amino Acid Transporter 1

Overview
Journal Nature
Specialty Science
Date 2017 Apr 21
PMID 28424515
Citations 116
Authors
Affiliations
Soon will be listed here.
Abstract

Human members of the solute carrier 1 (SLC1) family of transporters take up excitatory neurotransmitters in the brain and amino acids in peripheral organs. Dysregulation of the function of SLC1 transporters is associated with neurodegenerative disorders and cancer. Here we present crystal structures of a thermostabilized human SLC1 transporter, the excitatory amino acid transporter 1 (EAAT1), with and without allosteric and competitive inhibitors bound. The structures reveal architectural features of the human transporters, such as intra- and extracellular domains that have potential roles in transport function, regulation by lipids and post-translational modifications. The coordination of the allosteric inhibitor in the structures and the change in the transporter dynamics measured by hydrogen-deuterium exchange mass spectrometry reveal a mechanism of inhibition, in which the transporter is locked in the outward-facing states of the transport cycle. Our results provide insights into the molecular mechanisms underlying the function and pharmacology of human SLC1 transporters.

Citing Articles

Inhibitory Potential of the Truncated Isoforms on Glutamate Transporter Oligomerization Identified by Computational Analysis of Gene-Centric Isoform Maps.

Karagol A, Karagol T, Li M, Zhang S Pharm Res. 2024; 41(11):2173-2187.

PMID: 39487385 PMC: 11599315. DOI: 10.1007/s11095-024-03786-z.


Loss of Carbamoyl Phosphate Synthetase 1 Potentiates Hepatocellular Carcinoma Metastasis by Reducing Aspartate Level.

Chen S, Tang Q, Hu M, Song S, Wu X, Zhou Y Adv Sci (Weinh). 2024; 11(45):e2402703.

PMID: 39387452 PMC: 11615744. DOI: 10.1002/advs.202402703.


Succinate Dehydrogenase and Human Disease: Novel Insights into a Well-Known Enzyme.

Esteban-Amo M, Jimenez-Cuadrado P, Serrano-Lorenzo P, de la Fuente M, Simarro M Biomedicines. 2024; 12(9).

PMID: 39335562 PMC: 11429145. DOI: 10.3390/biomedicines12092050.


Molecular Dynamic Simulations Reveal that Water-Soluble QTY-Variants of Glutamate Transporters EAA1, EAA2 and EAA3 Retain the Conformational Characteristics of Native Transporters.

Karagol A, Karagol T, Zhang S Pharm Res. 2024; 41(10):1965-1977.

PMID: 39322794 PMC: 11530497. DOI: 10.1007/s11095-024-03769-0.


Structural basis of the excitatory amino acid transporter 3 substrate recognition.

Qiu B, Boudker O bioRxiv. 2024; .

PMID: 39282329 PMC: 11398500. DOI: 10.1101/2024.09.05.611541.


References
1.
Choi K, Jen J, Choi S, Shin J, Kim H, Kim H . Late-onset episodic ataxia associated with SLC1A3 mutation. J Hum Genet. 2016; 62(3):443-446. DOI: 10.1038/jhg.2016.137. View

2.
Zerangue N, Kavanaugh M . Flux coupling in a neuronal glutamate transporter. Nature. 1996; 383(6601):634-7. DOI: 10.1038/383634a0. View

3.
Rothstein J, van Kammen M, Levey A, Martin L, Kuncl R . Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol. 1995; 38(1):73-84. DOI: 10.1002/ana.410380114. View

4.
Waterhouse A, Procter J, Martin D, Clamp M, Barton G . Jalview Version 2--a multiple sequence alignment editor and analysis workbench. Bioinformatics. 2009; 25(9):1189-91. PMC: 2672624. DOI: 10.1093/bioinformatics/btp033. View

5.
Emsley P, Lohkamp B, Scott W, Cowtan K . Features and development of Coot. Acta Crystallogr D Biol Crystallogr. 2010; 66(Pt 4):486-501. PMC: 2852313. DOI: 10.1107/S0907444910007493. View